AKR7A2 Antibodies

Santa Cruz Biotechnology features a diverse variety of AKR7A2 monoclonal antibodies for research focused on understanding aldo-keto reductase family 7 member A2 protein. AKR7A2 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKR7A2 plays a crucial role in the metabolism of endogenous and exogenous compounds, contributing to the detoxification processes within cells. The aldo-keto reductase family 7 member A2 protein is involved in the reduction of aldehydes and ketones, which is essential for maintaining cellular homeostasis and protecting against oxidative stress. Understanding AKR7A2 function is vital for elucidating its implications in various diseases, including cancer and metabolic disorders. Researchers worldwide rely on AKR7A2 monoclonal antibodies to explore cellular pathways and mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and advance understanding of human health and disease.